Compound ID | 162
Class: Bioengineered honey
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Surgihoney may be the first biotechnology product with enhanced antimicrobial properties to be used successfully in wound management and could have advantages over chemical products and antibiotics in wound dressings in promoting healing and counteracting antimicrobial resistance. |
| Institute where first reported: | Surgihoney™,UK |
| Year first mentioned: | 2015 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |